Technavio has been monitoring the global board games market size and it is poised to grow by USD 5.81 billion during 2020-2024. However, the market is expected to decelerate at a CAGR of over 15% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201012005073/en/
Technavio has announced its latest market research report titled Global Board Games Market 2020-2024 (Graphic: Business Wire).
Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. We offer $1000 worth of FREE customization
The market is fragmented, and the degree of fragmentation will decelerate during the forecast period. Asmodee Holding, Clementoni Spa, CMON Ltd., Goliath Games LLC, Hasbro Inc., Mattel Inc., Monte Cook Games LLC, PD-Verlag, Ravensburger
Apple’s upcoming iPhone 12 lineup is likely to see major performance and efficiency improvements thanks to the A14 Bionic Processor.
Our first glimpse at the A14 comes from the just announced iPad Air 4, which is the first device to sport the next-generation Apple-designed processor. The 64-bit desktop-class A14 Bionic chip sees a considerable leap in performance and efficiency, according to Apple.
Early benchmarks suggest that the A14 is a 6-core chip with a base frequency of 2.99GHz and 3.66GB of memory, achieving a score of 1,583 in single-core and 4,198 for multi-core.
This is markedly higher than the 1,336 in single-core and 3,569 in multi-core for the A13 Bionic from 2019’s iPhone 11 lineup. Roughly compared, that means the iPhone 12 will be 18.4% faster in single-core performance and 17.6% faster than the current top-of-the-line iPhone. Here are speed comparisons of the upcoming iPhone 12 processor with other recent
A team of researchers in the United States and Japan reports that spinal cord stimulation (SCS) measurably decreased pain and reduced motor symptoms of Parkinson’s disease, both as a singular therapy and as a “salvage therapy” after deep brain stimulation (DBS) therapies were ineffective.
Writing in the September 28, 2020 issue of Bioelectronic Medicine, first author Krishnan Chakravarthy, MD, PhD, assistant professor of anesthesiology at University of California San Diego School of Medicine, and colleagues recruited 15 patients with Parkinson’s disease, a neurodegenerative disorder that is commonly characterized by physical symptoms, such as tremors and progressive difficulty walking and talking, and non-motor symptoms, such as pain and mental or behavioral changes.
The mean age of the patients was 74, with an average disease duration of 17 years. All of the patients were experiencing pain not alleviated by previous treatments. Eight had undergone earlier DBS, a non-invasive, pain therapy in